Abacavir and lamivudine for systemic lupus
Treatments studied
Part of Immune system & allergy, Skin clinical trials.
This study tests a combination of two antiviral pills (abacavir and lamivudine) to see if they can help people with systemic lupus. It may calm the immune system and reduce lupus symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 12 and 65 years old and weigh more than 25 kg (about 55 pounds).
- You need a formal diagnosis of systemic lupus (SLE) by a doctor using standard criteria.
- Your lupus should be well controlled or only mildly active at the moment.
- If you could get pregnant, you must use reliable birth control during the study.
- You cannot have HIV, hepatitis B or C, or be taking certain other medications.
- You must have normal kidney and liver function.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage trial tests a new drug called ABBV-519 given as infusions or injections to treat systemic lupus erythematosus (SLE) or rheumatoid arthritis (RA) in adults whose disease hasn't responded well to other treatments. Researchers will measure how safe the drug is, how it moves through your body, and whether it helps reduce symptoms.
This trial tests a new treatment, UB-VV410, for people with active systemic lupus erythematosus (SLE) or lupus nephritis (kidney inflammation caused by lupus) that hasn't responded to standard treatments. It aims to see if this therapy can help control the disease.
This study tests a new drug called LBL-047 in healthy people and in people with mild to moderate lupus. It helps check if the drug is safe and how the body processes it. Participating may help find better treatments for lupus.
This study tests a new medicine called E6742 to help people with systemic lupus erythematosus (SLE), an autoimmune disease where the body attacks its own tissues. Researchers want to see if this drug can reduce lupus symptoms and disease activity.
This study tests an experimental daily pill (BI 3000202) for people with active lupus (SLE) to see if it can reduce disease activity. It compares different doses against a placebo, and you must already be on stable lupus background treatment.
This study tests a new drug called A-319 for people whose lupus (SLE) is active or hasn't improved with current treatments. The goal is to see if A-319 can help control lupus better.
Hear when a new Systemic Lupus Erythematosus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.